Main Menu

ICR-CTSU Integrative Genomic Analysis in Clinical Trials

Dr Maggie Cheang’s multidisciplinary team of statistical, computational and translational scientists analyses large datasets generated from bio-specimens collected in clinical trials to study the underlying biology of tumours.

Team leader

Dr Maggie Cheang

Dr Maggie Cheang

Team Leader

Dr Maggie Cheang develops genomics classifiers for tumour subtypes and determines their clinical utility to predict sensitivity of each tumour type to therapeutic agents in phase II and III clinical trials. She co-invented the 50 genes-based classifier for the intrinsic subtypes of breast cancer, commonly known as PAM50.

ORCID 0000-0001-5718-2501

Team members

Dr Zsolt Szijgyarto